GL1X · GenesisL1 explorer

MolNFT v1 · #45869 · protein

Binding of two substrate analogue molecules to dihydroflavonol-4- reductase alters the functional geometry of the catalytic site

2NNL · Dihydroflavonol 4-reductase: “Binding of two substrate analogue molecules to dihydroflavonol-4- reductase alters the functional geometry of…”. X-ray diffraction, 2 ligands (NAP, ERD), 3 pockets (best druggability 0.81). MolNFT v1…

PDB
2NNL
Type
protein
Length
650 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroflavonol 4-reductase
EC
1.1.1.219
UniProt
P93799
Ligands
NAP, ERD
Pockets
3 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
DDihydroflavonol 4-reductase (EC 1.1.1.219)protein32444% helix, 16% strandP93799
FDihydroflavonol 4-reductase (EC 1.1.1.219)protein32643% helix, 16% strandP93799

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains D, F
  • ERD · (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one · ligand · 2 copies · chains D, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16410.810.8566NAP, ERD
26520.800.8471NAP, ERD
34760.610.7556empty

Interfaces

1 interface between chains.

  • D–F · 83 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 2NNL · Binding of two substrate analogue molecules to dihydroflavonol-4-reductase alters the… · the same entry in another collection · chain D against D, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.